Kaleido Biosciences, Inc.

KLDO · OTC
Analyze with AI
12/31/2021
9/30/2021
6/30/2021
3/31/2021
Assets
Cash & Equivalents$38,474$55,657$71,979$92,362
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,837$5,294$2,624$2,670
Total Curr. Assets$42,311$55,657$74,603$95,032
Property Plant & Equip (Net)$5,665$7,339$7,526$7,833
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$2,161$4,808$2,161$2,161
Total NC Assets$7,826$12,147$9,687$9,994
Other Assets$0$0$0$0
Total Assets$50,137$67,804$84,290$105,026
Liabilities
Payables$5,670$3,559$2,695$2,412
Short-Term Debt$16,144$6,384$3,667$4,759
Tax Payable$0$0$0$0
Deferred Revenue$828$150$189$281
Other Curr. Liab.$7,040$9,168$5,718$5,421
Total Curr. Liab.$29,682$19,261$12,269$12,873
LT Debt$5,550$15,132$17,677$16,433
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,298$4,211$4,078$3,946
Total NC Liab.$9,848$19,343$21,755$20,379
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$39,530$38,604$34,024$33,252
Equity
Pref Stock$0$0$0$0
Common Stock$43$43$43$42
Retained Earnings-$364,467-$344,195-$321,110-$297,221
AOCI$0$0$0$0
Other Equity$375,031$373,352$371,333$368,953
Total Equity$10,607$29,200$50,266$71,774
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$50,137$67,804$84,290$105,026
Net Debt-$16,780-$34,141-$50,635-$71,170